- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/02 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
Patent holdings for IPC class C07D 263/02
Total number of patents in this class: 39
10-year publication summary
|
1
|
3
|
1
|
1
|
2
|
0
|
1
|
2
|
1
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Merck Sharp & Dohme LLC | 3737 |
3 |
| ChemoCentryx, Inc. | 361 |
2 |
| DENTSPLY International Inc. | 335 |
2 |
| Huntsman Petrochemical LLC | 310 |
2 |
| The Scripps Research Institute | 1344 |
2 |
| Boehringer Ingelheim International GmbH | 4486 |
1 |
| Allergan, Inc. | 2157 |
1 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 309 |
1 |
| Abbvie Inc. | 1799 |
1 |
| Agios Pharmaceuticals, Inc | 227 |
1 |
| Auspex Pharmaceuticals, Inc. | 131 |
1 |
| Biota Scientific Management Pty Ltd. | 26 |
1 |
| Chong Kun Dang Pharmaceutical Corp. | 250 |
1 |
| Emory University | 1723 |
1 |
| Gracel Display Inc. | 18 |
1 |
| La Trobe University | 69 |
1 |
| Marquette University | 173 |
1 |
| Oryzon Genomics S.A. | 103 |
1 |
| Pécsi Tudományegyetem | 62 |
1 |
| Other owners | 11 |